Nwr Communications

Nwr Communications company information, Employees & Contact Information

Updated May 2026

Quick answer

Nwr Communications is a Public Relations and Communications Services company and founded in 2007. It has approximately 50 employees on record. Contact data was last refreshed in May 2026. Find Nwr Communications's verified employee emails, phone numbers, headquarters address, and key decision makers below.

NWR Communications is an investor and media relations firm with offices in Melbourne, Sydney and Perth. We work with a range of small-to-mid cap ASX-listed companies. We work with clients to build awareness and relationships within the investment community and media.

Company Details

Employees
50
Founded
-
Address
350 Collins Street, Level 6,australia
Phone
+61 420 582 887
Email
ti****@****.com.au
Industry
Public Relations And Communications Services
NAICS
Public Relations Agencies
HQ
Melbourne , VIC
Looking for a particular Nwr Communications employee's phone or email?

Nwr Communications Questions

News

Financial Results Webinar - GlobeNewswire

Financial Results Webinar GlobeNewswire

Radiopharm Theranostics Doses First Patient in Phase 1 'HEAT' Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors - Investing News Network

Radiopharm Theranostics Doses First Patient in Phase 1 'HEAT' Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors Investing News Network

Perseus Mining Quarterly Report Investor Webinar - GlobeNewswire

Perseus Mining Quarterly Report Investor Webinar GlobeNewswire

McLaren Minerals – Drilling Commenced at McLaren Titanium Project, WA - GOLDINVEST.de

McLaren Minerals – Drilling Commenced at McLaren Titanium Project, WA GOLDINVEST.de

Everest Metals Greenstone Belts Update Highlights Gold and Critical Minerals - Discovery Alert

Everest Metals Greenstone Belts Update Highlights Gold and Critical Minerals Discovery Alert

Appointment of Managing Director and Chief Executive Officer - GlobeNewswire

Appointment of Managing Director and Chief Executive Officer GlobeNewswire

Five-Year Gold Production Outlook Webinar - GlobeNewswire

Five-Year Gold Production Outlook Webinar GlobeNewswire

Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee - Investing News Network

Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee Investing News Network

Webinar notification – IKE’s quarterly performance update - BusinessDesk

Webinar notification – IKE’s quarterly performance update BusinessDesk

Aroa Biosurgery Launches New Product, Myriad Morcells™ - Offering Highly Conformable Tissue Regeneration in Wound Beds - Following Recent FDA Clearance - Business Wire

Aroa Biosurgery Launches New Product, Myriad Morcells™ - Offering Highly Conformable Tissue Regeneration in Wound Beds - Following Recent FDA Clearance Business Wire

Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases - Investing News Network

Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases Investing News Network

Change to Perseus's Senior Management Team - GlobeNewswire

Change to Perseus's Senior Management Team GlobeNewswire

Vonex : to present at virtual conference, Friday 27 March - MarketScreener

Vonex : to present at virtual conference, Friday 27 March MarketScreener

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart - Investing News Network

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart Investing News Network

Nyanzaga Gold Project Technical Report - GlobeNewswire

Nyanzaga Gold Project Technical Report GlobeNewswire

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - Investing News Network

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 Investing News Network

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake - Investing News Network

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake Investing News Network

Avecho and Sandoz enter Exclusive License and Development Agreement to Commercialise CBD for Insomnia in Australia - Investing News Network

Avecho and Sandoz enter Exclusive License and Development Agreement to Commercialise CBD for Insomnia in Australia Investing News Network

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia - GlobeNewswire

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia GlobeNewswire

Investor Webinar – 3pm AEST Tuesday 2 July - Investing News Network

Investor Webinar – 3pm AEST Tuesday 2 July Investing News Network

Top Nwr Communications Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant